MedTrace Logo

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

NCT00919139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 190

Last updated 2015-04-03

No results posted yet for this study

Summary

RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors find better ways to ways to treat the cancer.

PURPOSE: The purpose of this study is to collect and store blood and bone marrow samples from patients with multiple myeloma, smoldering myeloma, Waldenstrom's macroglobulinemia, amyloidosis, and monoclonal gammopathy of undetermined significance to be tested in the laboratory.

Conditions

  • Multiple Myeloma
  • Smoldering Myeloma
  • Waldenstrom's Macroglobulinemia
  • Monoclonal Gammopathy of Undetermined Significance
  • Amyloidosis

Interventions

OTHER

biologic sample preservation procedure

Blood and 3-4 cc bone marrow aspirate collected at same time (in association with treatment protocols on which patient is registered)

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • SWOG Cancer Research Network

    lead NETWORK

Principal Investigators

  • Joshua Espstein, DSC · University of Arkansas

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00919139 on ClinicalTrials.gov